nav-left cat-right
cat-right

Euroscreen Receives Key US Patent Covering Screeni...

CCR5 Chemokine Receptor is a Crucial Target for a Novel AIDS Therapy. Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent in the area of HIV infection. The patent claims screening methods using the human CCR5 receptor. Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent in the area of HIV...

Phylogica: new drug lead targeting stroke damage

Phylogica discovers new drug lead targeting stroke to reduce brain damage Australian biotechnology company Phylogica (www.phylogica.com)has discovered proprietary compounds that protect brain cells under conditions that simulate stroke. “Compared to the current gold standard for preventing damage to nerve cells under these conditions, three of Phylogica’s compounds were between two- and five-fold more...

Protein ATF2’role in DNA repair

Researchers at the Burnham Institute found that a protein known for its role in gene regulation has another important function, that of initiating DNA repair. The study has been published in Molecular Cell. Ze’ev Ronai, director of the Institute’s Signal Transduction Program, and his colleagues found that the protein ATF2 ( Activating Transcription Factor-2 ) is activated by a protein kinase called ATM (...

Animal Pharm: In Vivo Models in Drug Development

By John Hallock Bio-IT World (05/24/05)—With the costs of populating drug pipelines rising sharply, drug companies are exploring new in vivo animal models to guide early pre-clinical drug development. Despite a plethora of available technologies to discern biological mechanisms, the relevance of such technologies is only as good as the physiological models to which they are applied. A complete picture of the biological...

Emerging Drug Discovery Technologies: Building Com...

DUBLIN, Ireland, May 6 /PRNewswire/ — Research and Markets (http://www.researchandmarkets.com/reports/c17061 ) has announced the addition of Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi to their offering. Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, is a new report which provides...
Page 40 of 40« First...102030...3637383940